Should you build or buy 340B Drug Discount Management & Compliance?

340B Drug Discount Management & Compliance software helps covered entities and drug manufacturers track, validate, and report on participation in the federal 340B drug discount program — detecting duplicate discounts across contract pharmacy networks, managing manufacturer dispute resolution, and maintaining HRSA audit documentation.

Copy reviewed 2026-09-19 · Research revision 2026-09-05

Buy the engine, build the layer above it. Split billing, replenishment, virtual inventory, contract-pharmacy reconciliation and HRSA-ready audit evidence are what Craneware Sentinel and Sentrex, Verity 340B and Macro Helix 340B Architect exist to do, and a full in-house replacement makes sense only for a large manufacturer or a very large health system with real data-engineering depth. What you should own is the part that determines your capture rate: EHR-to-pharmacy-to-purchasing feeds, NDC and package-size crosswalks, payer and Medicaid carve-out logic, patient and prescription eligibility rules, and your own exception dashboards. Know what you are buying, too — Apexus is HRSA Prime Vendor program infrastructure rather than a split-billing engine, and 340B ESP is Second Sight's manufacturer claims-data exchange, not an operating platform. Before signing with a distributor-linked vendor, settle data-export rights and portability.

Build it, buy it, or bridge?

⚒ Build it
✓ Buy it
➔ Bridge
Cost shape
Estimate implementation, retained services, integration, validation, and ongoing operations for the defined scope.
Per-claim or subscription fees; consolidation may push pricing up
Vendor platform plus custom analytics layer on top of pharmacy data feeds
Time to value
Depends on the defined scope, data readiness, integrations, and production acceptance tests.
Quick deployment; dispute workflows and HRSA reporting built in
Vendor handles compliance baseline; custom analytics added over time
Differentiation captured
Institution-specific matching tuned to your contract pharmacy network
Shared platform logic; differentiation from configuration, not code
Standard compliance baseline plus proprietary analytics on dispute risk
AI feasibility today
A competitive vendor analytics market does not establish covered entities building the full core themselves. The documented pattern retains specialist program tooling.
Vendors adding ML dispute probability scoring and anomaly detection
Build the internal data layer and analysis around the program; retain services for accumulation, replenishment, rule maintenance, and audit evidence.
Who it fits
Teams with a defined need for the internal data layer and analysis around the program and capacity to operate it.
Most covered entities needing audit-defensible compliance documentation
Organizations with analytics capability wanting to extend vendor compliance base

When building makes sense

Consider an internal build for the internal data layer and analysis around the program. A competitive vendor analytics market does not establish covered entities building the full core themselves. The documented pattern retains specialist program tooling.

When buying makes sense

Buying earns its keep when you need accumulation, replenishment, rule maintenance, and audit evidence. Compare the vendor’s coverage with the staff, integrations, and controls an internal option would need. Custom extensions can remain useful without replacing the core.

The desk read

Consider an internal build for the internal data layer and analysis around the program. A competitive vendor analytics market does not establish covered entities building the full core themselves. The documented pattern retains specialist program tooling.

Buying earns its keep when you need accumulation, replenishment, rule maintenance, and audit evidence. Compare the vendor’s coverage with the staff, integrations, and controls an internal option would need. Custom extensions can remain useful without replacing the core.

Representative vendors Kalderos (Truzo, now Model N)Apexus / 340B ESP (Second Sight)Kalderos (Truzonow Model N)Verity SolutionsThe Craneware Group (Sentinel/Sentrex)

Vendors in 340B Drug Discount Management & Compliance

Each file covers what the product is, its funding history, and when the index last verified it alive.

Frequently asked

What is 340B Drug Discount Management & Compliance software?

340B Drug Discount Management & Compliance software helps covered entities and drug manufacturers track, validate, and report on participation in the federal 340B drug discount program — detecting duplicate discounts across contract pharmacy networks, managing manufacturer dispute resolution, and maintaining HRSA audit documentation.

When does building 340B compliance software make sense?

Consider an internal build for the internal data layer and analysis around the program. A competitive vendor analytics market does not establish covered entities building the full core themselves. The documented pattern retains specialist program tooling.

When does buying 340B compliance software make sense?

Buying earns its keep when you need accumulation, replenishment, rule maintenance, and audit evidence. Compare the vendor’s coverage with the staff, integrations, and controls an internal option would need. Custom extensions can remain useful without replacing the core.

What are the main 340B Drug Discount Management vendors?

Representative vendors include Kalderos (Truzo, now Model N), Apexus / 340B ESP (Second Sight), Kalderos (Truzo, now Model N), Verity Solutions, The Craneware Group (Sentinel/Sentrex). B4 Pro includes the category score and the full vendor list.

The B4 Index scores every software category on two axes, strategic differentiation and AI feasibility, to classify it Build, Buy, Bridge, or Beware. See the full methodology.